Skip to content

The clinical study of the effect of VC on visual function in diabetes retinopathy

The clinical study of the effect of VC on visual function in diabetes retinopathy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094412
Enrollment
Unknown
Registered
2024-12-23
Start date
2024-11-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic retinopathy

Interventions

Intravenous infusion group:Intravenous vitamin C infusion
Oral medication group:Oral Vitamin C
Intravenous infusion control group:None
Oral drug control group:Oral placebo

Sponsors

General Hospital of Xinjiang Military Region
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Age greater than 40 and less than 70, generally in good condition, able to cooperate with this study for follow-up after informed consent; 2. Patients in the city; 3. No long-term history of other drug use except for blood sugar control drugs; 4. There are no other eye diseases such as glaucoma and high myopia that affect the observation of DR fundus.

Exclusion criteria

Exclusion criteria: 1. Patients with severe systemic comorbidities who cannot tolerate surgery; 2. Patients with urinary tract stones who cannot tolerate oral vitamin C.

Design outcomes

Primary

MeasureTime frame
Plasma vitamin C concentration;

Countries

China

Contacts

Public ContactTian Yanming

Xinjiang PLA general hospital

tianyanming@163.com+86 195 2991 5579

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026